Answers are grounded in this paper and cite their sources.
Osteoarthritis (OA) is the most prevalent chronic arthropathy worldwide, affecting more than 600 million individuals, with its prevalence projected to increase substantially by 2050. Although extracellular vesicles (EVs) are increasingly recognized as mediators of intercellular communication and tissue remodeling in OA, their role in regulating mitochondrial homeostasis within the joint remains incompletely understood. Emerging evidence indicates that EVs can influence mitochondrial biology through diverse cargo, including non-coding RNAs, mRNAs, proteins, lipids, mitochondrial DNA, and mitochondrial material. These signals regulate interconnected processes including oxidative phosphorylation, redox homeostasis, mitophagy, mitochondrial dynamics, inter-organelle communication, and mitochondrial inflammatory signaling. Conversely, mitochondrial dysfunction can alter EV cargo and promote the extracellular dissemination of mitochondrial stress signals, establishing a potentially self-reinforcing relationship between mitochondrial damage and intercellular communication during OA progression. In this review, we critically examine the EV–mitochondrial axis across joint tissues, emphasizing defined cargo–target–mitochondrial pathways, inter-tissue communication, and the distinction between protective and pathogenic EV–mitochondrial signaling. We further discuss how these mechanistic insights are informing endogenous and engineered EV-based therapeutic strategies and evaluate the manufacturing, standardization, potency, and safety challenges that must be addressed for clinical translation.
No takes yet. Share an insight, caveat, or question.
Konteles et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: